{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:03:48Z","timestamp":1769691828979,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Childhood-onset systemic lupus erythematosus (SLE) is associated with greater disease activity, more aggressive course, and high rates of organ damage. The prolonged use of corticosteroids in childhood SLE contributes to increased morbidity, including avascular necrosis (AVN). We conducted this retrospective study using claims data from the Taiwan National Health Insurance Research Database, enrolling 1,472 children with newly-diagnosed SLE between 2005 and 2013. The mean age at the diagnosis of SLE was 15.5\u2009\u00b1\u20093.3\u00a0years, and the female to male ratio was 6.2:1. Thirty-nine patients (2.6%) developed symptomatic AVN during a mean follow-up of 4.6\u2009\u00b1\u20092.5\u00a0years. In multivariate analysis, the risk of AVN was higher in the patients with a daily prednisolone dose between 7.5\u00a0mg and 30\u00a0mg (HR 7.435, 95% CI 2.882\u201319.178, p\u2009&lt;\u20090.001) and over 30\u00a0mg (HR 9.366, 95% CI 2.225\u201339.418, p\u2009=\u20090.002) than in those with a dose\u2009\u2264\u20097.5\u00a0mg\/day. In addition, AVN was inversely correlated with the use of hydroxychloroquine\u2009&gt;\u2009627\u00a0days (HR 0.335, 95% CI 0.162\u20130.694, p\u2009=\u20090.003). In conclusion, high daily doses of prednisolone were associated with a significant risk of AVN, whereas the use of hydroxychloroquine\u2009&gt;\u2009627\u00a0days conferred an advantage. We suggest that the judicious use of corticosteroids combined with hydroxychloroquine might be a promising preventive strategy for AVN.<\/jats:p>","DOI":"10.1038\/s41598-020-71923-w","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T10:03:36Z","timestamp":1600855416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Epidemiology and risk factors for avascular necrosis in childhood systemic lupus erythematosus in a Taiwanese population"],"prefix":"10.1038","volume":"10","author":[{"given":"Hsin-Lin","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jei-Wen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Her","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Su","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"71923_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrrheum.2011.15","volume":"7","author":"HI Brunner","year":"2011","unstructured":"Brunner, H. I., Huggins, J. & Klein-Gitelman, M. S. Pediatric SLE-towards a comprehensive management plan. Nat. Rev. Rheumatol. 7, 225\u2013233 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"71923_CR2","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/01.bor.0000169364.69066.1e","volume":"17","author":"A Ravelli","year":"2005","unstructured":"Ravelli, A., Ruperto, N. & Martini, A. Outcome in juvenile onset systemic lupus erythematosus. Curr. Opin. Rheumatol. 17, 568\u2013573 (2005).","journal-title":"Curr. Opin. Rheumatol."},{"issue":"4","key":"71923_CR3","first-page":"700","volume":"35","author":"T Nevskaya","year":"2017","unstructured":"Nevskaya, T., Gamble, M. P. & Pope, J. E. A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors. Clin. Exp. Rheumatol. 35(4), 700\u2013710 (2017).","journal-title":"Clin. Exp. Rheumatol."},{"key":"71923_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1053\/sarh.2002.33724b","volume":"32","author":"Y Assouline-Dayan","year":"2002","unstructured":"Assouline-Dayan, Y., Chang, C., Greenspan, A., Shoenfeld, Y. & Gershwin, M. E. Pathogenesis and natural history of osteonecrosis. Semin. Arthritis Rheum. 32, 94\u2013124 (2002).","journal-title":"Semin. Arthritis Rheum."},{"key":"71923_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00296-010-1597-9","volume":"32","author":"M Sayarlioglu","year":"2012","unstructured":"Sayarlioglu, M. et al. Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus. Rheumatol. Int. 32, 177\u2013182 (2012).","journal-title":"Rheumatol. Int."},{"key":"71923_CR6","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1001\/jama.1960.03030080028005","volume":"174","author":"EL Dubois","year":"1960","unstructured":"Dubois, E. L. & Cozen, L. Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. JAMA 174, 966\u2013971 (1960).","journal-title":"JAMA"},{"key":"71923_CR7","first-page":"152","volume":"30","author":"W Kunyakham","year":"2012","unstructured":"Kunyakham, W., Foocharoen, C., Mahakkanukrauh, A., Suwannaroj, S. & Nanagara, R. Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients. Asian Pac. J. Allergy Immunol. 30, 152\u2013157 (2012).","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"71923_CR8","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1177\/0961203311412096","volume":"20","author":"D Pineles","year":"2011","unstructured":"Pineles, D. et al. Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus 20, 1187\u20131192 (2011).","journal-title":"Lupus"},{"key":"71923_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1586\/eci.09.29","volume":"5","author":"ED Papadimitraki","year":"2009","unstructured":"Papadimitraki, E. D. & Isenberg, D. A. Childhood- and adult-onset lupus: an update of similarities and differences. Expert. Rev. Clin. Immunol. 5, 391\u2013403 (2009).","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"71923_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.rdc.2009.12.012","volume":"36","author":"R Mina","year":"2010","unstructured":"Mina, R. & Brunner, H. Pediatric lupus are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?. Rheum. Dis. Clin. N. Am. 36, 53\u201380 (2010).","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"71923_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3899\/jrheum.160340","volume":"44","author":"B Artim-Esen","year":"2017","unstructured":"Artim-Esen, B. et al. Comparison of disease characteristics, organ damage, and survival in patients with juvenile-onset and adult-onset systemic lupus erythematosus in a combined cohort from 2 tertiary centers in Turkey. J. Rheumatol. 44, 619\u2013625 (2017).","journal-title":"J. Rheumatol."},{"key":"71923_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/rheumatology\/ket330","volume":"53","author":"YM Chen","year":"2014","unstructured":"Chen, Y. M. et al. Onset age affects mortality and renal outcome of female systemic lupus erythematosus patients: a nationwide population-based study in Taiwan. Rheumatology (Oxford) 53, 180\u2013185 (2014).","journal-title":"Rheumatology (Oxford)"},{"key":"71923_CR13","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1177\/0961203316644333","volume":"25","author":"N Ambrose","year":"2016","unstructured":"Ambrose, N. et al. Differences in disease phenotype and severity in SLE across age groups. Lupus 25, 1542\u20131550 (2016).","journal-title":"Lupus"},{"key":"71923_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12969-018-0274-5","volume":"16","author":"P Jongvilaikasem","year":"2018","unstructured":"Jongvilaikasem, P., McNeil, E. B., Dissaneewate, P. & Vachvanichsanong, P. Improvement of survival rates in the last decade in Thai childhood-onset systemic lupus erythematosus. Pediatr. Rheumatol. Online J. 16, 62 (2018).","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"71923_CR15","first-page":"781","volume":"111","author":"RM Hurley","year":"1974","unstructured":"Hurley, R. M., Steinberg, R. H., Patriquin, H. & Drummond, K. N. Avascular necrosis of the femoral head in childhood systemic lupus erythematosus. Can. Med. Assoc. J. 111, 781\u2013784 (1974).","journal-title":"Can. Med. Assoc. J."},{"key":"71923_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0022-3476(74)80281-7","volume":"85","author":"JM Bergstein","year":"1974","unstructured":"Bergstein, J. M., Wiens, C., Fish, A. J., Vernier, R. L. & Michael, A. Avascular necrosis of bone in systemic lupus erythematosus. J. Pediatr. 85, 31\u201335 (1974).","journal-title":"J. Pediatr."},{"key":"71923_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/art.10072","volume":"46","author":"HI Brunner","year":"2002","unstructured":"Brunner, H. I., Silverman, E. D., To, T., Bombardier, C. & Feldman, B. M. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheumatol. 46, 436\u2013444 (2002).","journal-title":"Arthritis Rheumatol."},{"key":"71923_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/art.11205","volume":"49","author":"A Ravelli","year":"2003","unstructured":"Ravelli, A. et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheumatol. 49, 501\u2013507 (2003).","journal-title":"Arthritis Rheumatol."},{"key":"71923_CR19","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/rheumatology\/kep067","volume":"48","author":"E Descloux","year":"2009","unstructured":"Descloux, E. et al. Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus. Rheumatology (Oxford) 48, 779\u2013784 (2009).","journal-title":"Rheumatology (Oxford)"},{"key":"71923_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12969-018-0271-8","volume":"16","author":"JKK Sit","year":"2018","unstructured":"Sit, J. K. K. & Chan, W. K. Y. Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study. Pediatr. Rheumatol. Online J. 16, 56 (2018).","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"71923_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12969-015-0008-x","volume":"13","author":"R Gurion","year":"2015","unstructured":"Gurion, R. et al. Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature. Pediatr. Rheumatol. Online J. 13, 13 (2015).","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"71923_CR22","doi-asserted-by":"publisher","first-page":"P329","DOI":"10.1186\/1546-0096-12-S1-P329","volume":"12","author":"L Bogmat","year":"2014","unstructured":"Bogmat, L., Shevchenko, N. & Matvienko, E. Use of SLICC\/ACR damage index in adolescents with SLE. Pediatr. Rheumatol. 12, P329 (2014).","journal-title":"Pediatr. Rheumatol."},{"key":"71923_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/art.30102","volume":"62","author":"J Nakamura","year":"2010","unstructured":"Nakamura, J. et al. Age at onset of corticosteroid administration is a risk factor for osteonecrosis in pediatric patients with systemic lupus erythematosus: a prospective magnetic resonance imaging study. Arthritis Rheumatol. 62, 609\u2013615 (2010).","journal-title":"Arthritis Rheumatol."},{"key":"71923_CR24","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.3899\/jrheum.150464","volume":"42","author":"Y Yang","year":"2015","unstructured":"Yang, Y., Kumar, S., Lim, L. S., Silverman, E. D. & Levy, D. M. Risk factors for symptomatic avascular necrosis in childhood-onset systemic lupus erythematosus. J. Rheumatol. 42, 2304\u20132309 (2015).","journal-title":"J. Rheumatol."},{"key":"71923_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1148\/radiology.175.1.2315484","volume":"175","author":"SG Moore","year":"1990","unstructured":"Moore, S. G. & Dawson, K. L. Red and yellow marrow in the femur: age-related changes in appearance at MR imaging. Radiology 175, 219\u2013223 (1990).","journal-title":"Radiology"},{"key":"71923_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.gene.2018.05.091","volume":"671","author":"A Wang","year":"2018","unstructured":"Wang, A., Ren, M. & Wang, J. The pathogenesis of steroid-induced osteonecrosis of the femoral head: a systematic review of the literature. Gene 671, 103\u2013109 (2018).","journal-title":"Gene"},{"key":"71923_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ecl.2012.04.004","volume":"41","author":"RS Weinstein","year":"2012","unstructured":"Weinstein, R. S. Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol. Metab. Clin. N. Am. 41, 595\u2013611 (2012).","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"71923_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jsbmb.2009.02.007","volume":"114","author":"MA Kerachian","year":"2009","unstructured":"Kerachian, M. A., S\u00e9guin, C. & Harvey, E. J. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J. Steroid. Biochem. Mol. Biol. 114, 121\u2013128 (2009).","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"issue":"4","key":"71923_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/0961203307076771","volume":"16","author":"SC Fialho","year":"2007","unstructured":"Fialho, S. C. et al. Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus. Lupus 16(4), 239\u2013244 (2007).","journal-title":"Lupus"},{"key":"71923_CR30","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1007\/s10753-014-9917-y","volume":"37","author":"KK Zhu","year":"2014","unstructured":"Zhu, K. K. et al. The risk factors of avascular necrosis in patients with systemic lupus erythematosus: a meta-analysis. Inflammation 37, 1852\u20131864 (2014).","journal-title":"Inflammation"},{"key":"71923_CR31","first-page":"761","volume":"28","author":"DD Gladman","year":"2001","unstructured":"Gladman, D. D., Urowitz, M. B., Chaudhry-Ahluwalia, V., Hallet, D. C. & Cook, R. J. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J. Rheumatol. 28, 761\u2013765 (2001).","journal-title":"J. Rheumatol."},{"key":"71923_CR32","first-page":"284","volume":"20","author":"RA Asherson","year":"1993","unstructured":"Asherson, R. A. et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J. Rheumatol. 20, 284\u2013288 (1993).","journal-title":"J. Rheumatol."},{"key":"71923_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/acr.21779","volume":"65","author":"DM Levy","year":"2013","unstructured":"Levy, D. M. et al. Influence of ethnicity on childhood-onset systemic lupus erythematosus: Results from a multiethnic multicenter Canadian cohort. Arthritis Care Res. 65, 152\u2013160 (2013).","journal-title":"Arthritis Care Res."},{"key":"71923_CR34","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.3899\/jrheum.081141","volume":"36","author":"LT Hiraki","year":"2019","unstructured":"Hiraki, L. T. et al. Ethnic differences in pediatric systemic lupus erythematosus. J. Rheumatol. 36, 2539\u20132546 (2019).","journal-title":"J. Rheumatol."},{"key":"71923_CR35","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1191\/0961203304lu1075xx","volume":"13","author":"K Alsaeid","year":"2004","unstructured":"Alsaeid, K., Kamal, H., Haider, M. Z., Al-Enezi, H. M. & Malaviya, A. N. Systemic lupus erythematosus in Kuwaiti children: organ system involvement and serological findings. Lupus 13, 613\u2013617 (2004).","journal-title":"Lupus"},{"key":"71923_CR36","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00467-005-1900-2","volume":"20","author":"A Bakr","year":"2005","unstructured":"Bakr, A. Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt. Pediatr. Nephrol. 20, 1081\u20131086 (2005).","journal-title":"Pediatr. Nephrol."},{"key":"71923_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/RHU.0b013e3181ba3423","volume":"15","author":"P Uea-areewongsa","year":"2009","unstructured":"Uea-areewongsa, P., Chaiamnuay, S., Narongroeknawin, P. & Asavatanabodee, P. Factors associated with osteonecrosis in Thai lupus patients: a case control study. J. Clin. Rheumatol. 15, 345\u2013349 (2009).","journal-title":"J. Clin. Rheumatol."},{"key":"71923_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00003086-200105000-00022","volume":"386","author":"JW Pritchett","year":"2001","unstructured":"Pritchett, J. W. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin. Orthop. Relat. Res. 386, 173\u2013178 (2001).","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"1","key":"71923_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11926-010-0141-y","volume":"13","author":"M Petri","year":"2011","unstructured":"Petri, M. Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients. Curr. Rheumatol. Rep. 13(1), 77\u201378 (2011).","journal-title":"Curr. Rheumatol. Rep."},{"issue":"1","key":"71923_CR40","first-page":"29","volume":"17","author":"J Al Saleh","year":"2010","unstructured":"Al Saleh, J. et al. Predictors of avascular necrosis of the hip in Emiratis patients with systemic lupus erythematosus. Egypt. J. Immunol. 17(1), 29\u201340 (2010).","journal-title":"Egypt. J. Immunol."},{"issue":"5","key":"71923_CR41","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00296-014-3147-3","volume":"35","author":"YB Joo","year":"2015","unstructured":"Joo, Y. B. et al. Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study. Rheumatol. Int. 35(5), 879\u2013886 (2015).","journal-title":"Rheumatol. Int."},{"issue":"6","key":"71923_CR42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.phrs.2012.09.004","volume":"66","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y., Zeng, X. & Jin, S. Autophagy in adipose tissue biology. Pharmacol. Res. 66(6), 505\u2013512 (2012).","journal-title":"Pharmacol. Res."},{"issue":"11","key":"71923_CR43","first-page":"3329","volume":"119","author":"R Singh","year":"2009","unstructured":"Singh, R. et al. Autophagy regulates adipose mass and differentiation in mice. J. Clin. Investig. 119(11), 3329\u20133339 (2009).","journal-title":"J. Clin. Investig."},{"key":"71923_CR44","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/ard.61.8.718","volume":"61","author":"F Buttgereit","year":"2002","unstructured":"Buttgereit, F. et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann. Rheum. Dis. 61, 718\u2013722 (2002).","journal-title":"Ann. Rheum. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71923-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71923-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71923-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:10:34Z","timestamp":1670353834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71923-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["71923"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-71923-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"10 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15563"}}